For many people living with depression, anxiety, obsessive-compulsive disorder (OCD), or other mental health conditions, treatment begins with medication. While medication can be an important part of care, finding the right option is not always straightforward.

It is common for patients to spend months—or even years—adjusting dosages, switching prescriptions, or trying different combinations before finding meaningful improvement. This process is not a reflection of the patient’s effort or the physician’s expertise. Rather, it reflects the reality that every brain functions differently.

Computational brain mapping offers a different starting point.

Instead of relying primarily on symptom observation and medication response over time, Neurotherapeutix begins by evaluating how brain networks communicate.

Using advanced functional imaging and patented computational brain mapping, our team develops individualized treatment plans designed around each patient’s unique connectivity patterns.

This information can then be used to guide fMRI-guided TMS therapy and other treatment decisions, creating a more personalized path forward for individuals who feel stuck in a cycle of trial and error.

When medication becomes a process of elimination

Medication remains one of the most common treatments for depression and other mental health conditions.

For many individuals, it can provide meaningful symptom relief and improve quality of life.

However, medication management is often a process of refinement rather than immediate precision.

How medication management typically works

When a patient begins treatment, clinicians make recommendations based on symptoms, diagnosis, medical history, and clinical experience.

From there, treatment often involves:

• Starting a medication
• Monitoring response
• Adjusting dosage
• Evaluating side effects
• Trying alternatives when necessary

Because individuals respond differently to medications, it can take time to determine which option is the best fit.

Why it can take months—or years—to find the right fit

Mental health medications typically require several weeks before their full effects can be evaluated.

If symptoms do not improve, adjustments may be needed. Sometimes the medication works partially. Sometimes side effects become problematic. Sometimes another medication is added or substituted.

Over time, this process may involve multiple treatment attempts.

For patients who have already spent months or years navigating medication changes, the experience can become frustrating and emotionally exhausting.

For example, according to the National Institute of Mental Health, major depression affects millions of adults each year, and many individuals require multiple treatment attempts before finding an approach that provides meaningful symptom improvement.

This reality helps explain why medication management can become a lengthy process of adjustment and observation rather than a straightforward path to relief.

What “treatment-resistant” actually means

The term treatment-resistant depression generally refers to depression that has not adequately improved after multiple appropriate treatment attempts.

This does not mean a person cannot improve.

Instead, it often indicates that additional treatment approaches may be needed.

For many individuals seeking treatment for depression, persistent symptoms despite medication can become the reason they begin exploring alternatives such as functional brain imaging and fMRI-guided TMS therapy.

What brain mapping adds to the picture

Computational brain mapping is not a replacement for medication.

Rather, it provides an additional layer of information that can help clinicians better understand how a patient’s brain networks function.

Instead of focusing solely on symptoms, brain mapping evaluates the communication patterns occurring beneath those symptoms.

How fMRI-based imaging identifies functional connectivity patterns

At Neurotherapeutix, the process begins with patented computational brain mapping supported by advanced rsfMRI imaging.

Resting-state functional MRI measures blood oxygen level-dependent (BOLD) signals while the brain is at rest. These signals help reveal how different regions of the brain communicate within larger functional networks.

Rather than examining brain anatomy alone, the imaging evaluates functional connectivity—the relationships between neural systems involved in mood regulation, emotional processing, cognition, attention, and behavior.

What the data shows about individual brain differences

Two people may receive the same diagnosis while experiencing very different underlying network patterns.

One patient with depression may demonstrate connectivity changes involving emotional regulation circuits. Another may show disruptions involving cognitive control networks.

These differences help explain why individuals can respond differently to the same treatment.

Computational brain mapping allows clinicians to move beyond diagnosis alone and evaluate how a specific patient’s brain functions.

Why one-size-fits-all approaches may miss the mark

Traditional treatment approaches often begin with what is most likely to help based on population-level data.

Computational brain mapping starts with information about the individual.

This does not eliminate clinical judgment or replace other forms of treatment. Instead, it provides additional insight that may support more personalized decision-making.

From imaging to treatment planning

Collecting imaging data is only the beginning.

The value comes from how that information is translated into individualized treatment planning.

How rsfMRI findings inform stimulation targeting

After imaging is completed, Neurotherapeutix’s patented computational brain mapping platform analyzes functional connectivity patterns throughout the brain.

This analysis helps identify:

• Underactive networks
• Overactive networks
• Connectivity disruptions
• Neural circuits associated with symptoms

The goal is to understand how the patient’s brain networks communicate and where intervention may be most appropriate.

Targeting circuits tied to a patient’s specific symptoms

Once connectivity patterns have been analyzed, clinicians can use that information to help guide treatment planning.

For patients pursuing fMRI-guided TMS therapy, imaging data helps identify individualized stimulation targets based on network function rather than generalized positioning methods.

This approach recognizes that symptoms arise from neural circuits, not simply diagnoses.

How the approach differs from generalized anatomical landmarks

Standard TMS therapy protocols often rely on anatomical landmarks to determine stimulation locations.

Neurotherapeutix takes a different approach.

Using computational brain mapping and rsfMRI findings, clinicians evaluate where symptom-related networks are functioning within that patient’s brain before treatment begins.

This allows for individualized targeting based on functional connectivity rather than solely on anatomical assumptions.

What this means for the treatment timeline

One of the most common questions patients ask is whether brain mapping prolongs the treatment process.

The answer depends on how the timeline is measured.

Consultation and computational brain mapping before treatment begins

An fMRI-guided approach involves additional evaluation before treatment starts.

Patients first complete consultations, imaging, and computational analysis before individualized treatment planning occurs.

This requires more upfront assessment than simply beginning a medication trial.

Ongoing monitoring and targeting adjustments

The additional information gathered at the beginning may help support more informed treatment decisions moving forward.

Rather than relying exclusively on symptom response to guide adjustments, clinicians can incorporate connectivity data and individualized treatment planning into the decision-making process.

When to consider this approach

Many patients explore brain mapping after:

• Multiple medication trials
• Partial improvement from medications
• Persistent symptoms
• Previous standard TMS therapy
• Interest in a more personalized treatment strategy

For these individuals, understanding how their brain networks function may provide useful information when considering next steps.

Taking a closer look at your brain

If you have spent years navigating medication changes, dosage adjustments, or treatment approaches that did not provide the improvement you hoped for, it may feel as though you have run out of options.

In reality, you may simply need more information.

Computational brain mapping offers a way to evaluate how your brain networks function before making treatment decisions. At Neurotherapeutix, this information helps guide individualized care using advanced functional imaging, connectivity analysis, and fMRI-guided TMS therapy.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, Neurotherapeutix provides a uniquely personalized approach designed around how your brain actually functions.

If you are interested in learning whether this approach may be appropriate for you, request an appointment to speak with our team.

Frequently asked questions

How is computational brain mapping different from a standard psychiatric evaluation?

A standard psychiatric evaluation focuses on symptoms, medical history, treatment history, and clinical assessment.

Computational brain mapping adds objective functional imaging data that helps clinicians evaluate how brain networks communicate and how those patterns may relate to symptoms.

Can computational brain mapping be used alongside medication?

Yes. Computational brain mapping does not replace medication. In many cases, it may be used alongside medication management, psychotherapy, or other treatment approaches as part of a comprehensive treatment plan.

Is fMRI-guided TMS therapy right for me if I’ve tried antidepressants without success?

It may be appropriate for some individuals who have not experienced adequate improvement from medication alone. Eligibility is determined through a clinical evaluation that considers symptoms, treatment history, and overall health.

Does Neurotherapeutix accept insurance?

Neurotherapeutix is a private-pay practice. We do not submit claims, communicate with insurance companies, or manage reimbursement requests on behalf of patients. However, we provide visit documentation, clinical records, and billing information for patients who choose to pursue reimbursement independently.

How do I get started?

The first step is a consultation. During the evaluation process, clinicians review your symptoms, treatment history, and goals to determine whether computational brain mapping and fMRI-guided TMS therapy may be appropriate for your needs.

Additional answers to common questions can also be found in our FAQ resources.

The effectiveness of brain stimulation depends on more than the stimulation itself. It also depends on where that stimulation is delivered.

Standard transcranial magnetic stimulation (TMS) therapy and fMRI-guided TMS therapy use the same non-invasive technology, but they approach treatment planning very differently.

A standard approach relies on fixed anatomical landmarks based on population averages, whereas an individualized approach uses each patient’s functional brain imaging and connectivity data to identify person‑specific treatment targets.

Understanding that distinction can help answer an important question: Why does precision matter?

At Neurotherapeutix, our approach begins with fMRI-guided TMS therapy, using functional connectivity data to guide individualized treatment planning.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, we believe understanding where stimulation is delivered is just as important as the stimulation itself.

What is standard TMS therapy and how does it work?

Standard TMS therapy has helped expand access to non-invasive brain stimulation and has become an established treatment option for several mental health conditions.

According to the National Institute of Mental Health, TMS therapy uses magnetic pulses to stimulate specific areas of the brain involved in mood, cognition, and emotional regulation. It is commonly used when symptoms have not adequately improved with first-line treatments.

Understanding how standard TMS therapy works provides an important foundation for understanding how fMRI-guided approaches differ.

The mechanism: magnetic pulses and cortical stimulation

TMS therapy uses a magnetic coil positioned against the scalp to generate focused magnetic pulses.

These pulses pass through the skull and influence activity within targeted brain circuits. Over time, repeated stimulation may help support neuroplasticity, the brain’s ability to strengthen and reorganize neural connections.

Patients remain awake during treatment and can typically return to normal daily activities afterward.

Understanding how TMS therapy works provides useful context for comparing standard and connectivity-guided approaches.

How targets are selected in standard protocols

Most standard TMS therapy protocols identify treatment targets using scalp measurements and generalized anatomical landmarks.

For example, clinicians may approximate a stimulation site in the dorsolateral prefrontal cortex using scalp measurements or established positioning formulas. These methods are widely used and supported by clinical research, but they rely on external head measurements and group‑average data rather than the patient’s own brain anatomy, so the actual stimulation site can be substantially off and may not even fall fully within the true dorsolateral prefrontal region.

In practice, this means a fixed anatomical spot on the scalp is treated as if it reliably corresponds to the intended cortical target, even though it does not guarantee that stimulation reaches the same brain region or functional network in every patient..

The challenge is that both brain structure and connectivity can differ from person to person, so a ‘standard’ scalp location can map to different underlying tissue and network organization across patients. This variability is one reason Neurotherapeutix focuses on fMRI‑guided, personalized targeting that is based on each patient’s own brain networks rather than generalized anatomical assumptions.

What FDA clearance for standard TMS therapy covers

FDA-cleared TMS therapy protocols have demonstrated effectiveness for several conditions and have helped expand access to non-invasive brain stimulation.

Today, repetitive transcranial magnetic stimulation (rTMS) is FDA-cleared for:

• Treatment-resistant depression
• Obsessive-compulsive disorder (OCD)
• Migraines
• Anxiety symptoms associated with depression
• Smoking dependence

However, TMS therapy does not produce the same therapeutic effects as electroconvulsive therapy (ECT), and it is not approved for children younger than 15 years old.

These clearances are based on standardized treatment approaches that have helped many patients.

The question is not whether standard TMS therapy works. It clearly can.

The question is whether a more individualized understanding of brain connectivity may help improve how treatment targets are selected.

What “fMRI-guided” means in practice

The term “fMRI-guided” refers to the use of functional magnetic resonance imaging (fMRI) to help determine where stimulation should be delivered.

Instead of relying solely on anatomical estimates, clinicians evaluate how brain networks communicate and use that information to guide treatment planning.

This is where Neurotherapeutix differs from traditional TMS providers.

Resting-state fMRI and functional connectivity mapping

At Neurotherapeutix, treatment begins with advanced imaging.

Resting-state functional MRI (rsfMRI) measures blood oxygen level-dependent (BOLD) signals while the brain is at rest. These signals help reveal how different brain regions communicate within larger functional networks.

Rather than simply identifying where structures are located, rsfMRI helps clinicians understand how neural systems interact.

This information serves as the foundation of our patented computational brain mapping process, which analyzes functional connectivity patterns across the brain to identify individualized treatment targets.

From imaging to individualized targeting coordinates

Once imaging data is collected, Neurotherapeutix’s patented computational brain mapping platform performs advanced analysis of connectivity patterns throughout the brain.

Clinicians can identify:

• Underactive networks
• Overactive networks
• Disrupted communication pathways
• Connectivity patterns associated with symptoms

This information helps determine individualized stimulation targets based on the patient’s own functional network architecture.

Rather than asking, “Where is the target usually located?” the question becomes, “Where is the target located in this particular brain?”

Why anatomical landmarks and functional networks don’t always match

Brain anatomy may look similar between individuals, but functional connectivity can vary significantly.

Research on connectivity-guided neuromodulation has shown that two patients with the same diagnosis may exhibit different network-level patterns that contribute to their symptoms.

This means that a generalized anatomical location may not always correspond to the same functional target from one person to the next.

The goal of fMRI-guided TMS therapy is to reduce that uncertainty by incorporating patient-specific network information into treatment planning.

Comparing the two approaches side by side

Both standard TMS therapy and fMRI-guided TMS therapy use magnetic stimulation. The primary difference lies in how treatment targets are selected.

Targeting method: anatomical estimate vs. functional network data

Standard TMS therapy identifies targets based on generalized positioning techniques.

fMRI-guided TMS therapy uses each patient’s connectivity patterns to identify stimulation targets based on how their brain networks function.

Role of pre-treatment imaging

Most standard protocols do not require functional imaging before treatment.

At Neurotherapeutix, advanced imaging is the first step in the treatment process because it provides the data used for computational brain mapping and individualized treatment planning.

Understanding the differences between rsfMRI and SPECT imaging can help clarify why Neurotherapeutix relies on functional connectivity analysis when developing individualized treatment plans.

How treatment planning differs

Standard approaches focus on applying an established protocol.

fMRI-guided treatment planning begins with understanding the individual’s brain network architecture before determining where stimulation should be delivered.

Monitoring and adjustment during treatment

Both approaches involve ongoing clinical monitoring.

However, fMRI-guided treatment planning provides a more detailed understanding of the underlying network targets being addressed throughout care.

Why precision in targeting matters for outcomes

Brain stimulation is ultimately about influencing neural circuits.

The more accurately those circuits can be identified, the more precisely treatment can be directed.

Individual differences in brain network architecture

No two brains are wired the same way.

While patients may share diagnoses such as depression, anxiety, or OCD, the specific connectivity patterns contributing to symptoms can vary significantly.

This variation is one reason personalized treatment planning has become an area of increasing interest within neuroscience and psychiatry.

What happens when stimulation misses the intended circuit

If stimulation is delivered to a location that does not correspond to the intended functional network, treatment may still influence the brain, but not necessarily the circuit most closely associated with symptoms.

This does not mean standard TMS therapy is ineffective.

It means there may be value in understanding individual network architecture before selecting treatment targets.

How personalized targeting may improve the signal-to-noise ratio

One way to think about individualized targeting is through signal-to-noise ratio.

The goal is to maximize stimulation of the intended network while minimizing unnecessary variability.

By incorporating functional connectivity data into planning, clinicians can deliver stimulation with greater specificity and less reliance on generalized assumptions.

Who may benefit most from fMRI-guided TMS therapy?

Not every patient arrives at treatment for the same reason.

Some individuals are exploring TMS therapy for the first time. Others have already tried medications, psychotherapy, or even standard TMS therapy without achieving their desired results.

Those who haven’t responded to standard TMS therapy

Some patients seek evaluation after completing standard TMS therapy elsewhere.

In these situations, individualized connectivity analysis may provide additional information about treatment targets and network-level contributors to symptoms.

Complex presentations with overlapping conditions

Many patients experience more than one condition at the same time.

For example:

• Depression and anxiety
• PTSD and depression
• OCD and anxiety
• Cognitive symptoms alongside mood concerns

These overlapping presentations may involve multiple interacting networks rather than a single isolated circuit.

People who want a data-informed approach from the start

Some individuals simply prefer a more individualized approach from the beginning.

Rather than relying on generalized positioning methods, they want treatment planning informed by functional imaging and patient-specific connectivity data.

This is particularly common among individuals seeking treatment for depression who want a deeper understanding of how their symptoms may relate to underlying brain network activity before beginning therapy.

The case for knowing where you’re stimulating

The conversation about TMS therapy often centers on whether brain stimulation works.

A more useful question may be: How do you decide where stimulation should be delivered?

Standard TMS therapy and fMRI-guided TMS therapy share the same core technology. The difference is the amount of information used to guide treatment planning.

Our expert team believes understanding your brain’s unique connectivity patterns provides an opportunity to move beyond generalized targeting and toward individualized care.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, Neurotherapeutix combines functional imaging, connectivity analysis, and individualized targeting to create treatment plans based on how each patient’s brain networks actually function.

If you would like to discuss whether fMRI-guided TMS therapy may be appropriate for your needs, request an appointment with our team.

Frequently asked questions

Is fMRI-guided TMS therapy the same as standard TMS therapy?

No. While both approaches use magnetic stimulation to influence brain activity, the primary difference is how treatment targets are selected.

Standard TMS therapy typically relies on anatomical landmarks to approximate where to stimulate, while fMRI-guided TMS therapy incorporates each patient’s individual functional connectivity data and computational analysis into treatment planning.

Does fMRI guidance mean the treatment takes longer?

The TMS therapy sessions themselves are generally similar. However, fMRI-guided treatment includes additional imaging and computational analysis before treatment begins to support individualized planning.

Is MRI safe? Does it use radiation?

MRI does not use ionizing radiation. According to the National Institute of Biomedical Imaging and Bioengineering, MRI uses magnetic fields and radio waves to generate images and is considered a non-invasive imaging modality when appropriate screening guidelines are followed.

Does Neurotherapeutix accept insurance?

Neurotherapeutix is a private-pay practice. We do not submit claims, communicate with insurance companies, or manage reimbursement requests on behalf of patients. However, we provide visit documentation, clinical records, and billing information for patients who choose to pursue reimbursement independently.

How do I find out if I’m a candidate for fMRI-guided TMS therapy?

The first step is a consultation. During the evaluation process, clinicians review your symptoms, medical history, prior treatments, and treatment goals to determine whether fMRI-guided TMS therapy may be appropriate for your situation.

Starting treatment for a mental health or neurological condition can feel overwhelming, especially when advanced imaging and personalized brain analysis are involved. Many patients want to understand what happens between the first consultation, the scan, and the start of treatment.

At Neurotherapeutix, the brain mapping approach is built around fMRI-based computational analysis, an advanced method that evaluates how different regions of the brain communicate.

Rather than relying on generalized anatomical assumptions, clinicians use functional connectivity data to identify the specific neural circuits involved in each patient’s symptoms.

From your initial consultation through your first TMS session, every step is designed to create a more personalized treatment strategy based on how your brain functions in real time.

What is the computational brain mapping process?

The computational brain mapping process combines functional imaging, clinical evaluation, and advanced analysis to better understand how different regions of the brain communicate.

At Neurotherapeutix, this process centers on resting-state functional MRI (rsfMRI), which measures functional connectivity across neural networks while the brain is at rest.

Unlike structural imaging alone, computational analysis evaluates how the brain functions in real time. This helps clinicians identify patterns of overactivity, underactivity, or disrupted communication that may contribute to symptoms involving mood, cognition, emotional regulation, and neurological function.

Why computational brain mapping comes first

Many traditional TMS approaches rely on generalized anatomical landmarks when selecting stimulation targets. Neurotherapeutix takes a more personalized approach.

By beginning with fMRI-based computational brain mapping, clinicians can identify the specific neural circuits associated with each patient’s symptoms before treatment starts.

Research has shown that connectivity-based targeting may improve treatment response by aligning stimulation with the brain networks most relevant to the condition being treated.

This precision-driven approach is central to Neurotherapeutix’s care model. It reflects the clinic’s position as the only clinical practice in the United States using patented fMRI-guided computational brain mapping to guide TMS therapy.

Step 1 — your initial consultation

The process begins with a detailed consultation and clinical evaluation.

During this stage, clinicians review your symptoms, treatment history, goals, and overall health to determine whether fMRI-guided TMS therapy may be appropriate for you.

This conversation helps establish the clinical context needed to interpret imaging results and personalize treatment planning.

Patients also learn more about how fMRI-guided TMS therapy works and what to expect throughout treatment.

This consultation is designed to go beyond a diagnosis alone. Two people with similar symptoms may have very different patterns of brain connectivity, which is why individualized evaluation is so important.

Step 2 — the rsfMRI brain scan

The next step is the resting-state fMRI (rsfMRI) scan.

During the scan, you will lie comfortably in an MRI machine while the system measures how different regions of your brain communicate at rest. Unlike task-based scans, rsfMRI does not require you to complete exercises or respond to prompts during imaging.

Instead of relying on limited task-based imaging, our scan captures functional connectivity patterns across neural networks in their natural resting state. This superior approach allows for a comprehensive, whole-brain analysis to map how networks interact. Research shows that analyzing this complete brain topology is actually the best predictor of behavior and task performance, giving us the most accurate map of your symptoms.

What the scanner is looking for

The scan evaluates how different brain regions interact and coordinate.

Clinicians analyze:

• Which networks may be overactive or underactive
• How emotional regulation circuits communicate
• Patterns associated with mood, cognition, and stress response
• Areas where connectivity may be disrupted

This information becomes the foundation for computational analysis and personalized treatment planning.

At Neurotherapeutix, our cutting-edge computational brain mapping technology identifies brain abnormalities with millimeter-level precision. This allows us to move beyond standard TMS approaches that rely on generalized anatomical locations. Instead, we can pinpoint the exact abnormal regions unique to your brain, guiding our targeting with significantly greater precision to create a truly personalized treatment plan.

Patients interested in learning more about imaging differences can also explore how rsfMRI compares to SPECT imaging.

Is the scan safe?

Yes. MRI and rsfMRI are non-invasive imaging methods that do not involve ionizing radiation.

According to the National Institute of Biomedical Imaging and Bioengineering, MRI uses magnetic fields and radio waves to generate detailed images without exposing patients to radiation.

The scanning process is completely painless and generally very well-tolerated by our patients. While the imaging machine does produce some loud sounds and can feel a bit cozy, our team will ensure you are comfortable and supported throughout the entire experience.

Step 3 — computational analysis and treatment planning

After the scan is completed, the imaging data undergoes computational analysis.

During this stage, we evaluate functional connectivity across your neural networks to identify specific patterns of disrupted activity. By providing a complete topology of your whole-brain activity, our clinicians can support specific clinical diagnoses and pinpoint the exact circuits associated with your symptoms. With this deep understanding, we then customize a precise treatment plan designed specifically for you, directly addressing the unique abnormalities causing your condition.

Rather than applying a standardized protocol, treatment planning is guided by how your brain is functioning individually.

How your brain connectivity map guides targeting

Your connectivity analysis acts as a blueprint for treatment.

Using this information, clinicians can:

• Identify personalized stimulation targets
• Align treatment with symptom-related circuits
• Adjust targeting based on your specific neural activity patterns

This precision-driven process is one of the key differences between fMRI-guided treatment and traditional TMS approaches.

Because targeting is based on your individual brain connectivity patterns rather than generalized anatomy, the goal is to support more meaningful and durable changes in neural function.

Step 4 — your first TMS session

Once the computational brain mapping analysis is complete and the specific targets for your personalized care have been identified, your treatment begins.

During your fMRI-guided TMS therapy session, we use advanced neuronavigational technology to guide your treatment in real time. You will actually be able to see your own brain on the screen as the software guides our clinicians, ensuring the magnetic coil is positioned directly on top of the precise, personalized targets we previously uploaded into the system.

The treatment uses magnetic pulses to stimulate the neural circuits involved in mood regulation, cognition, or emotional processing.

TMS is non-invasive and does not require anesthesia or sedation. Most sessions are completed in under an hour, and patients typically return to their normal daily activities afterward.

What to expect over a full treatment timeline

TMS therapy is a process that unfolds over time.

While some patients notice changes early, meaningful improvement often develops gradually as the brain adapts, strengthening correct neural pathways and creating healthy new patterns of connectivity. This process is tied to neuroplasticity — the brain’s ability to reorganize and form new neural pathways.

At Neurotherapeutix, treatment plans are designed not only to reduce symptoms but to support lasting changes in how brain networks function.

Throughout treatment, clinicians monitor progress and make adjustments as needed based on response and brain function.

Ready to see your brain?

The computational brain mapping process is the only way to truly personalize your treatment, ensuring your care is precise, exact, and informed from the very beginning.

By combining advanced imaging with computational analysis and individualized targeting, Neurotherapeutix helps patients better understand how their brain functions and how treatment can be tailored to their needs.

If you are ready to learn more about how fMRI-guided TMS therapy works or begin the process, you can request a consultation to speak with the team.

Frequently asked questions

Does everyone at Neurotherapeutix start with a brain scan?

Yes, all patients begin with computational analysis because it provides the functional data needed to personalize treatment targeting. Imaging is a central part of Neurotherapeutix’s precision-guided approach.

How long does the computational brain mapping process take from scan to first session?

The timeline from your initial consultation to your first treatment is highly efficient. After your consultation, your fMRI scan is usually scheduled immediately, typically taking place within 2 to 3 days. Once the scan is complete, our comprehensive computational brain mapping analysis takes exactly one week. As soon as those results are finalized and your specific treatment targets are identified, your fMRI-guided TMS sessions can begin.

Will I see my brain map?

Yes. Clinicians review imaging findings with patients as part of the treatment planning process and explain how the results relate to symptoms and targeting.

What if I’ve already had standard TMS — does the process change?

Patients who have previously undergone standard TMS with limited success, no success, or even a worsening of symptoms can still benefit immensely from our fMRI-guided approach. We have successfully treated many patients in this exact situation. Because our advanced computational brain mapping evaluates your unique, individual brain connectivity rather than relying on generalized anatomical assumptions, we are able to pinpoint the exact root of the problem and fully personalize a treatment that finally works for you.

Does insurance cover the rsfMRI scan?

Neurotherapeutix is a private-pay practice. We do not submit claims, contact insurance companies, or handle reimbursement matters on behalf of patients. Instead, we provide visit summaries, superbills, medical records, and billing documentation so patients can independently pursue out-of-network reimbursement if they choose to do so.

When it comes to brain stimulation, small differences in location can have a significant impact.

The brain is not organized into broad, isolated regions working independently. It functions through highly interconnected neural networks, many of which are separated by only millimeters but serve very different roles in mood regulation, cognition, emotional processing, and behavior.

This is why precision matters.

At Neurotherapeutix, computational brain mapping is used to identify the specific neural circuits underlying each patient’s symptoms before treatment begins.

Rather than relying on generalized anatomical assumptions, clinicians use fMRI-based connectivity analysis and neuronavigation to guide stimulation with millimeter-level accuracy.

This precision-driven approach is one of the defining differences between standard TMS protocols and personalized fMRI-guided treatment.

The problem with “close enough” in brain stimulation

In many areas of medicine, “close enough” may still produce acceptable results. In brain stimulation, however, even slight differences in targeting can affect which neural networks are being stimulated.

Two treatment targets may appear anatomically similar while functioning very differently within the brain’s connectivity system. Stimulating one network may support emotional regulation and symptom improvement, while stimulating a nearby but different circuit may produce less effective or inconsistent results.

This is especially important in mental health conditions, where symptoms are often linked to disruptions in network communication rather than visible structural abnormalities.

The challenge is not simply reaching the brain — it is reaching the right network with enough precision and consistency to influence how that network functions over time.

What standard TMS gets right — and what it can’t account for

Standard transcranial magnetic stimulation (TMS) has helped expand access to non-invasive brain stimulation and remains an important treatment option for many patients.

According to the National Institute of Mental Health, TMS is an established brain stimulation therapy used for certain mental health conditions.

However, traditional protocols often rely on generalized anatomical targeting methods based on average brain positioning rather than individual connectivity patterns.

This approach assumes that the same anatomical location will produce similar outcomes across patients, even though no two brains function exactly alike.

At Neurotherapeutix, the goal is to move beyond generalized positioning with fMRI-guided TMS therapy rather than standard TMS and to evaluate how each patient’s neural networks communicate individually.

This distinction is critical because symptoms such as depression, anxiety, post-traumatic stress disorder (PTSD), and cognitive dysfunction are often tied to network-level disruptions rather than a single isolated brain region.

What precision brain mapping actually measures

Precision brain mapping focuses on functional connectivity — how different regions of the brain communicate and coordinate with one another.

At Neurotherapeutix, this process is guided through rsfMRI, or resting-state functional MRI, which evaluates brain network activity while the patient is at rest.

Unlike structural imaging alone, rsfMRI helps clinicians understand how neural systems interact in real time.

From blood oxygen signals to a connectivity map

rsfMRI measures subtle fluctuations in blood oxygen levels, known as BOLD signals, which reflect neural activity across different brain regions.

By analyzing these signals computationally, clinicians can identify:

• Networks that may be overactive or underactive
• Patterns of disrupted communication
• Connectivity associated with mood, cognition, or emotional regulation

Research has shown that connectivity-based targeting may improve antidepressant response in TMS by aligning stimulation with symptom-related neural networks.

This information becomes the foundation for personalized targeting.

Patients interested in imaging comparisons can also explore rsfMRI vs. SPECT imaging to better understand how different technologies evaluate brain function.

How millimeter resolution translates to a treatment target

MRI technology offers extremely high spatial resolution, allowing clinicians to evaluate brain structures and connectivity patterns with remarkable detail.

In practical terms, this means clinicians can identify highly specific treatment targets rather than relying on generalized coordinates.

Millimeter-level accuracy matters because nearby brain regions may belong to entirely different neural networks. Precision targeting helps ensure stimulation is directed toward the circuits most closely associated with the patient’s symptoms.

How Neurotherapeutix achieves millimeter accuracy

At Neurotherapeutix, precision extends beyond the initial scan and continues throughout treatment.

Once imaging and computational analysis identify the appropriate target, clinicians use fMRI-guided TMS therapy protocols combined with neuronavigation technology to maintain highly accurate positioning during every session.

This approach helps ensure that treatment remains aligned with the intended neural circuits across the full course of therapy.

The role of neuronavigation in every TMS session

Neuronavigation acts as a real-time guidance system during treatment.

Using imaging data and spatial tracking, clinicians can precisely position the TMS coil relative to the patient’s individualized treatment target. This allows for consistent targeting session after session.

Without neuronavigation, even small shifts in positioning could alter which brain networks receive stimulation.

At Neurotherapeutix, maintaining precision across sessions is considered essential because consistent targeting supports more reliable network modulation over time.

Why consistent targeting across sessions matters

TMS therapy is not a one-time intervention. It works through repeated stimulation over multiple sessions as the brain gradually adapts and strengthens new connectivity patterns.

This process is tied to neuroplasticity — the brain’s ability to reorganize and form new neural pathways.

If targeting varies significantly between sessions, stimulation may not consistently engage the same neural circuits. Precision and consistency help reinforce the intended network changes throughout treatment.

This is one reason why individualized targeting and neuronavigation can play such an important role in treatment planning and long-term outcomes.

You can learn more about how it works now.

What this means for your treatment outcomes

For patients, precision-guided care means treatment is designed around how their brains function —not around generalized averages.

This may help:

• Improve targeting accuracy
• Better align stimulation with symptom-related networks
• Support more consistent modulation across sessions
• Create more meaningful and durable changes in connectivity

At Neurotherapeutix, precision is viewed as a clinical necessity rather than an added feature.

The goal is not simply to stimulate the brain, but to stimulate the right networks with the level of accuracy needed to support individualized treatment outcomes.

Precision starts here

At Neurotherapeutix, advanced imaging, computational analysis, and neuronavigation are integrated to create a more precise and personalized approach to brain stimulation.

By combining fMRI-guided targeting with millimeter-level accuracy, clinicians can tailor treatment to the neural circuits most closely associated with each patient’s symptoms.

If you are interested in learning more about precision-guided care, you can request a consultation to speak with the team.

Frequently asked questions

How precise is Neurotherapeutix’s brain mapping compared to standard TMS?

Standard TMS often relies on generalized anatomical landmarks, while Neurotherapeutix uses fMRI-guided computational brain mapping and neuronavigation to identify and target individualized neural circuits with millimeter-level accuracy.

What is neuronavigation, and how is it used during TMS sessions?

Neuronavigation is an advanced guidance system that uses imaging data and spatial tracking to allow clinicians to visualize the brain while the patient is comfortably seated in the treatment chair. This technology enables us to precisely position the coil over the exact brain regions identified during computational brain mapping. By continuously guiding placement and monitoring movement in real time, the system ensures highly accurate, consistent targeting across every session.

Does millimeter precision actually improve treatment outcomes?

Yes. Research suggests that connectivity-based targeting significantly improves treatment response by doing more than just providing millimeter precision. It allows us to detect the exact, specific regions of the brain that are malfunctioning for each patient. By aligning stimulation directly with these symptom-related neural networks, this precision targeting ensures a highly personalized approach and maintains consistent precision throughout the entire treatment course.

Does insurance cover fMRI-guided computational brain mapping?

Neurotherapeutix is a private-pay practice. We do not submit claims, contact insurance companies, or handle reimbursement matters on behalf of patients. Instead, we provide visit summaries, superbills, medical records, and billing documentation so patients can independently pursue out-of-network reimbursement if they choose.

Who is a good candidate for computational brain mapping?

Individuals seeking a highly personalized approach to TMS therapy are excellent candidates, particularly those with treatment-resistant conditions or prior experience with standard TMS.

Furthermore, patients with any symptoms are good candidates, as our computational brain mapping technology provides a thorough analysis of whole-brain activity and connectivity. This comprehensive evaluation supports specific diagnoses, uncovers the neurological root of your symptoms, and creates a personalized care plan by identifying the exact brain regions to target for treatment.

Anxiety in young adults is becoming a more common part of public conversation, and not just among clinicians. When public figures openly discuss panic attacks and burnout, it helps normalize experiences that many people struggle to explain.

Singer Shawn Mendes has spoken candidly about the emotional toll of constant performance pressure and why stepping back from touring was necessary to prioritize his mental health. His experience reflects a larger trend: many high-functioning young adults are navigating chronic stress, anxiety, and periods of emotional exhaustion while trying to maintain demanding personal or professional expectations.

Understanding why this happens requires looking not only at life circumstances, but also at how anxiety affects the brain and nervous system.

Why anxiety in young adults is on the rise

Young adulthood often involves significant transitions, including academic pressure, career decisions, financial stress, social comparison, and increased digital exposure. Over time, sustained stress can influence how the brain regulates emotional responses.

Many individuals experiencing anxiety still appear high functioning externally. They may continue working, studying, or performing at high levels while feeling exhausted or overwhelmed internally.

This disconnect between appearance and internal experience is one reason anxiety and burnout can build gradually before symptoms become obvious.

Shawn Mendes and panic attacks: A public case study

In interviews about his decision to pause touring, Shawn Mendes described feeling emotionally overwhelmed and disconnected from his sense of balance in life. He explained that constant performance expectations and public scrutiny contributed to growing mental and emotional strain.

While every person’s experience is unique, his story highlights common contributors to anxiety in young adults:

• Ongoing performance pressure
• Limited time for recovery or rest
• High visibility and external evaluation
• Difficulty separating identity from achievement

Public conversations like this help reduce stigma by showing that anxiety and panic symptoms can affect anyone, regardless of success or visibility.

What causes panic attacks in young adults?

Panic attacks are intense episodes of fear or discomfort that can appear suddenly, sometimes without an obvious trigger.

From a neuroscience perspective, panic symptoms often involve heightened activation of brain regions responsible for threat detection and stress response, particularly the amygdala and connected neural networks.

Contributing factors may include:

• Chronic stress exposure
• Sleep disruption
• Burnout or emotional overload
• High baseline anxiety
• Nervous system sensitivity

When these systems remain activated for extended periods, the brain may begin to respond to everyday situations as if they were threats.

Symptoms of panic attacks you should understand

Panic attacks can feel alarming, especially when symptoms mimic physical medical conditions.

Common symptoms include:

• Rapid heartbeat
• Shortness of breath
• Dizziness or lightheadedness
• Chest tightness
• Sweating or shaking
• Feeling detached or unreal
• Sudden intense fear

Symptoms typically peak within minutes, but the emotional aftereffects can linger longer.

The difference between anxiety and panic attacks

Anxiety and panic attacks are related but not identical.

Anxiety usually builds gradually and involves persistent worry or tension.

Panic attacks tend to occur suddenly and are characterized by intense physical symptoms.

Many individuals experience both, especially when chronic stress increases overall nervous system sensitivity.

How anxiety affects the brain and nervous system

Anxiety involves communication among several brain networks that regulate emotion, detect threats, and support cognitive control.

When stress becomes chronic, these circuits may become less balanced:

• The amygdala may become more reactive
• Stress hormones may remain elevated
• Communication between emotional and regulatory regions can weaken

This imbalance can make it harder to feel calm, even when no immediate danger exists.

Cortisol, burnout, and mental exhaustion

Cortisol is a hormone released during stress. In short bursts, it helps the body respond to challenges. But prolonged cortisol exposure may contribute to mental exhaustion, poor sleep, and emotional burnout.

Over time, chronic stress can lead to symptoms such as:

• Constant fatigue
• Difficulty concentrating
• Emotional numbness or irritability
• Feeling overwhelmed by simple tasks

Burnout and anxiety frequently overlap, especially in young adults managing high expectations without adequate recovery.

Neurobiology of anxiety and neuroplasticity

The good news is that the brain retains the ability to adapt. This process, called neuroplasticity, allows neural pathways to change over time in response to experiences and treatment.

Modern anxiety care increasingly focuses on supporting healthier communication between brain networks rather than only addressing symptoms at the surface level.

Standard anxiety treatment options for young adults

Standard anxiety treatment typically includes:

• Psychotherapy, such as cognitive behavioral therapy (CBT)
• Medication when clinically appropriate
• Stress management and lifestyle adjustments
• Mindfulness or biofeedback approaches

These strategies help many individuals. However, some continue to experience persistent symptoms despite appropriate care.

fMRI-guided TMS therapy for anxiety and panic disorders

For individuals seeking a non-medication, brain-based approach, neuromodulation may be considered.

Traditional TMS uses standard coil placement based on general anatomical landmarks. At Neurotherapeutix, fMRI-guided TMS therapy uses computational brain mapping to identify personalized neural connectivity patterns associated with symptoms.

This allows clinicians to:

• Personalize stimulation targets using imaging data
• Identify misfiring neural networks with millimeter-level precision
• Support healthier communication between brain regions involved in anxiety regulation

Because every brain is unique, treatment is designed around individual neural patterns rather than a standardized protocol.

When to seek professional help for anxiety

You may benefit from a professional evaluation if:

• Anxiety interferes with daily functioning
• Panic symptoms occur repeatedly
• Sleep or concentration are consistently affected
• Burnout or emotional exhaustion continues despite rest
• Symptoms persist or worsen over time

Early support can help prevent symptoms from becoming more entrenched.

Anxiety treatment in NYC at Neurotherapeutix

At Neurotherapeutix, our team provides personalized anxiety care using fMRI-guided TMS therapy in Manhattan.

Our physicians use functional MRI-based computational brain mapping to guide treatment decisions and expert services based on your unique brain connectivity patterns, helping support brain function and strengthen neural connections over time.

If you are exploring advanced anxiety treatment options in New York City, we invite you to request an appointment or contact our team directly to learn more.

FAQs about anxiety, panic attacks, and burnout

If you’ve been exploring treatment options for depression, anxiety, or other neurological or psychiatric conditions, you may be wondering whether transcranial magnetic stimulation (TMS) therapy is right for you.

TMS has become an increasingly recognized option for individuals seeking non-invasive, brain-based care, especially when symptoms persist despite traditional approaches. But candidacy is not based on a single factor. It involves understanding your history, symptoms, and how your brain networks may be functioning.

In this blog, we explain how TMS therapy works, who may qualify, and what to expect if you are considering treatment at Neurotherapeutix in New York City.

What is transcranial magnetic stimulation therapy?

Transcranial magnetic stimulation therapy is a non-invasive treatment that uses magnetic pulses to stimulate specific brain regions involved in mood regulation, emotional processing, and cognitive function.

How TMS therapy works

During treatment, a magnetic coil is placed near your scalp to deliver targeted pulses to brain regions associated with symptoms. These pulses are designed to support healthier communication between neural networks and promote neuroplasticity, which is the brain’s ability to adapt and reorganize.

TMS sessions are performed in an outpatient setting, and patients remain awake and alert throughout treatment.

Standard TMS vs. fMRI-guided TMS therapy

Traditional TMS uses standard coil placement based on general anatomical landmarks and follows protocol-based treatment approaches for most patients.

At Neurotherapeutix, fMRI-guided TMS therapy uses computational brain mapping to personalize stimulation targets based on your unique brain connectivity patterns. This allows clinicians to identify specific neural circuits involved in symptoms and tailor treatment with millimeter-level precision.

Because every brain is different, this approach is designed to reflect your individual neural pathways rather than rely on a one-size-fits-all protocol.

FDA-approved TMS therapy for mental health

According to the Cleveland Clinic, TMS therapy has received FDA clearance for certain mental health conditions, including depression and obsessive-compulsive disorder.

Clinicians may also explore its use for additional conditions based on individual needs, clinical judgment, and evolving neuroscience research.

Am I a candidate for fMRI-guided TMS therapy? Key signs to look for

You may be a strong candidate for fMRI-guided TMS therapy if:

• You continue to experience mental health or neurological symptoms despite therapy or medication
• You prefer a non-medication treatment approach
• You are looking for a non-invasive option with minimal downtime
• You want a more personalized treatment plan guided by brain imaging
• You are interested in advanced mental health care beyond standardized protocols

Candidacy is always determined through clinical evaluation rather than symptoms alone.

Who can get fMRI-guided TMS therapy?

TMS therapy may be considered for individuals experiencing conditions such as:

• Depression
• Anxiety disorders
• Obsessive-compulsive disorder (OCD)
• Post-traumatic stress disorder (PTSD)
• Bipolar-related depressive symptoms
• Certain neurological or brain injury–related conditions

At Neurotherapeutix, treatment planning begins with clinical review and functional MRI-based computational brain mapping to determine whether this approach aligns with your individual needs.

Is fMRI-guided TMS right for me? Important questions to consider

Deciding whether TMS therapy is a good fit often comes down to understanding your symptoms, treatment history, and personal goals.

These are some of the most common questions patients ask when considering whether fMRI-guided TMS therapy is appropriate for them.

How will TMS work for me?

Response varies from person to person. While many patients experience meaningful improvement, outcomes depend on factors such as symptom history, neural connectivity patterns, and overall clinical presentation.

Functional MRI-based computational brain mapping helps personalize treatment targeting, which may support more individualized care planning.

Do I need to stop medication before TMS?

Not necessarily. While many people explore TMS after trying medication or psychotherapy, treatment decisions are based on clinical evaluation rather than strict sequencing. Your care team considers your preferences, treatment history, and goals when determining next steps.

Who is not eligible for TMS?

Some individuals may not be suitable candidates for TMS therapy. Contraindications can include:

• Certain implanted metallic or electronic devices near the head
• Medical conditions that may increase seizure risk
• Other safety considerations identified during clinical evaluation

Your care team will review medical history and safety guidelines before recommending treatment.

Safety guidelines and side effects

TMS therapy is generally well-tolerated and does not require anesthesia or sedation. Common side effects are usually mild and temporary, and may include:

• Scalp discomfort during treatment
• Mild headache
• Temporary facial muscle twitching

Serious complications are rare, and safety screening is completed before treatment begins.

What to expect from fMRI-guided TMS treatment

Treatment typically follows several steps:

• Initial consultation and clinical review
• Functional MRI-based computational brain mapping
• Personalized targeting using imaging data
• A series of outpatient TMS sessions
• Ongoing monitoring and adjustments as needed

Sessions often last approximately 20–30 minutes, allowing most patients to return to normal activities afterward.

Why choose Neurotherapeutix in NYC for TMS therapy

Located on Manhattan’s Upper East Side, Neurotherapeutix is the first and only clinic in the United States to offer fMRI-guided TMS therapy using patented computational brain mapping technology.

Our physicians combine advanced neuroscience with compassionate, expert-led care designed to support brain function and strengthen neural connections through personalized treatment strategies.

Get started with fMRI-guided TMS therapy in NYC

If you are wondering whether you may be a candidate for TMS therapy, the best next step is a consultation with our team.

We take the time to understand your symptoms, treatment history, and goals so you can make informed decisions about your care.

Request an appointment or contact us directly to learn whether fMRI-guided TMS therapy may be appropriate for you.

FAQs about TMS eligibility and treatment

Anxiety and emotional distress do not always appear suddenly, and they do not discriminate based on status, success, or public image.

In a widely viewed 2021 interview with Oprah Winfrey, Meghan Markle spoke candidly about her mental health struggles while living under sustained public scrutiny. Her story brought renewed attention to how anxiety can develop under chronic stress, and why access to meaningful support is critical.

By sharing her experience, Markle helped shift the mental health conversation away from stereotypes and toward a more honest understanding of how anxiety affects people navigating prolonged pressure, isolation, and emotional overload.

The significance of Meghan Markle speaking out about mental health

Public conversations around mental health often change when lived experiences are shared openly.

Markle’s interview marked a moment where anxiety, emotional distress, and unmet support needs were discussed on a global stage without minimization or dismissal.

Her willingness to speak openly helped validate experiences many people struggle to articulate, especially when symptoms build quietly over time rather than appearing all at once.

What Meghan Markle has said about anxiety

During the interview, Markle described feeling increasingly isolated and overwhelmed after restrictions were placed on her daily activities. She shared that she rarely left the house for extended periods and felt emotionally trapped, despite outward appearances suggesting stability and support.

She explained that when she reached out for help, she felt her concerns were not addressed in a meaningful way.

Over time, this lack of support intensified feelings of anxiety, loneliness, and emotional distress, illustrating how anxiety can escalate when stressors remain unaddressed.

Celebrity anxiety and mental health stigma

Mental health stigma often thrives in silence. When high-profile individuals speak openly, it can challenge misconceptions and encourage broader understanding.

How public figures influence mental health awareness

Public figures have a unique ability to influence how mental health is perceived. When someone widely recognized discusses anxiety, it can help others:

• Recognize symptoms they may have dismissed
• Feel less alone in their experiences
• Understand that anxiety is not a personal weakness

These conversations can lower barriers to seeking care and normalize mental health as part of overall health.

The impact of celebrity anxiety stories on stigma

Stories like Markle’s reinforce that anxiety can affect anyone, regardless of external success. They help shift the narrative from judgment to empathy and encourage earlier, more open discussions about mental well-being.

Anxiety among high-profile individuals

Living in the public eye often involves constant evaluation, limited privacy, and prolonged exposure to stress. Over time, these conditions can affect how the brain regulates emotion and stress.

For high-profile individuals, anxiety may be compounded by:

• Continuous media scrutiny
• Lack of control over personal boundaries
• Pressure to maintain composure under distress
• Social isolation despite public visibility

These stressors can influence brain networks involved in emotional regulation, increasing vulnerability to anxiety symptoms.

Understanding anxiety disorders

Anxiety exists on a spectrum. While situational stress is common, anxiety disorders involve persistent symptoms that interfere with daily life.

Common symptoms and anxiety attacks explained

Anxiety symptoms can vary widely but often include:

• Persistent worry or fear that feels difficult to control
• Restlessness or feeling constantly “on edge”
• Racing thoughts or mental overload
• Physical tension, headaches, or muscle tightness
• Rapid heartbeat or shortness of breath
• Difficulty concentrating or sleeping

Anxiety attacks may involve sudden surges of fear accompanied by physical symptoms, even when no immediate danger is present.

When does anxiety become a mental health condition?

When symptoms persist, worsen, or disrupt daily functioning, anxiety may reflect an underlying mental health condition.

Professional evaluation can help determine appropriate care options and reduce the likelihood that symptoms will become more entrenched over time.

Anxiety treatment options available today

Anxiety care is often most effective when tailored to the individual and the underlying contributors to their symptoms.

Therapy, medication, and lifestyle approaches

Common treatment options include:

• Psychotherapy approaches such as cognitive behavioral therapy (CBT)
• Medication when clinically appropriate
• Stress-management strategies and sleep regulation
• Lifestyle adjustments that support nervous system balance

These approaches can be effective, especially when symptoms are addressed early.

When traditional anxiety treatments fall short

Some individuals continue to experience anxiety despite therapy or medication. In these cases, symptoms may reflect challenges in brain network regulation rather than purely psychological stressors. This has led to growing interest in brain-based treatment approaches that focus on how neural circuits function.

fMRI-guided TMS therapy for anxiety: A precision-based approach

Advances in neuroscience have made it possible to approach anxiety treatment through a more individualized, brain-based lens.

Rather than relying solely on symptom descriptions, fMRI-guided TMS therapy focuses on how anxiety affects functional communication within the brain.

How fMRI-guided TMS therapy works

fMRI-guided TMS therapy is a non-invasive treatment that combines transcranial magnetic stimulation with functional MRI–based computational brain mapping.

Functional MRI identifies patterns of brain connectivity involved in emotional regulation, threat response, and stress processing.

Using this data, stimulation targets are selected based on each individual’s unique neural network activity rather than standardized anatomical locations.

Magnetic pulses are then delivered to these specific circuits to support healthier communication between brain regions associated with anxiety.

Is fMRI-guided TMS effective for anxiety disorders?

Research suggests anxiety is linked to disrupted communication within specific brain networks involved in stress and emotional regulation.

A clinical study published in the Journal of Clinical Psychiatry found that fMRI-guided TMS was associated with meaningful reductions in anxiety symptoms for many participants when stimulation targets were selected using functional MRI.

Outcomes vary between individuals, but many patients explore this approach when symptoms persist despite traditional care or when they are seeking a non-medication, brain-based option.

At Neurotherapeutix, treatment planning is always guided by individual brain connectivity patterns and clinical evaluation, ensuring care remains personalized and data-informed.

Mental health advocacy and seeking help

Public discussions about anxiety help reinforce an important message: emotional distress deserves care and attention. Seeking support is not a sign of failure; it is a proactive step toward stability and long-term well-being.

Anxiety care at Neurotherapeutix in NYC

Neurotherapeutix offers personalized, brain-based anxiety care using fMRI-guided TMS therapy.

Located on Manhattan’s Upper East Side, our clinic combines advanced neuroimaging with expert-led, compassionate care to support mental health at the circuit level.

If you are exploring advanced anxiety treatment options in New York City, you can request an appointment or contact us directly to learn more about whether this approach may be appropriate for you.

Frequently asked questions about anxiety and TMS

Can TMS therapy help anxiety without medication?

fMRI-guided TMS therapy is non-invasive and does not involve medication. It may be explored as a standalone option or alongside other forms of care, depending on individual needs.

Is TMS therapy available in New York City?

Yes. Neurotherapeutix is located on Manhattan’s Upper East Side and is the only clinic in the country that offers fMRI-guided TMS therapy.

How long does TMS treatment for anxiety take?

Treatment length varies. Sessions are delivered over multiple weeks to support gradual changes in brain connectivity.

Do celebrity mental health stories encourage treatment?

Public stories can help reduce stigma and encourage individuals to recognize symptoms and seek professional support earlier.

When should someone seek professional anxiety care?

If anxiety symptoms persist, worsen, or interfere with daily life, professional evaluation can help guide appropriate next steps.

Public conversations about substance use and mental health often change when well-known individuals speak openly about their experiences. Visibility can reduce shame, increase understanding, and help others feel less alone in their own struggles.

Model and actress Cara Delevingne has shared that she reached a point where she needed help and entered rehab, describing recovery as an ongoing process rather than a single turning point. Her openness helped bring attention to the close connection between substance use and mental health.

Her story reflects an important reality: addiction rarely exists on its own. It is often linked to underlying mental health challenges that require thoughtful, long-term care.

What Cara Delevingne has shared about rehab

Delevingne has spoken publicly about realizing that her lifestyle was no longer sustainable and that she needed to step away to focus on her health. In a 2023 Vogue interview, she emphasized that, for her,  seeking treatment was not about weakness but about self-awareness and survival.

By acknowledging the need for support, she highlighted a message many people struggle to accept: recovery often begins with recognizing when something is no longer working.

Why her story sparked public mental health conversations

When a public figure talks openly about rehab, it challenges the idea that addiction and mental health struggles only affect certain people.

Delevingne’s story resonated because it showed that success, visibility, and access do not protect someone from emotional distress.

Her honesty helped normalize conversations about treatment, recovery, and the importance of addressing mental health alongside substance use.

Celebrity rehab stories and mental health awareness

Stories shared by celebrities often reach people who may not otherwise engage with mental health education. These moments can create space for more open and compassionate conversations.

How high-profile stories reduce mental health stigma

When public figures speak openly, it can help others:

• Recognize the signs of distress they may have ignored
• Feel less isolated in their experiences
• Understand that addiction and mental health challenges are medical and psychological issues, not personal failures

These conversations can make it easier for individuals to consider seeking help.

The influence of celebrities on seeking treatment

High-profile stories can encourage people to explore care earlier, rather than waiting until symptoms become overwhelming. Seeing recovery framed as a process, not a dramatic event, helps set more realistic expectations for healing.

The link between substance use and mental health disorders

Substance use and mental health conditions frequently overlap.

Anxiety, depression, trauma, and mood disorders can increase vulnerability to substance use, while ongoing use can worsen emotional regulation and stress response.

This two-way relationship means that addressing only substance use without considering mental health may leave key contributors untreated.

Mental health treatment for addiction recovery

Effective recovery often involves coordinated care that addresses both emotional health and behavioral patterns.

Treatment plans may include therapy, medical support, lifestyle changes, and ongoing monitoring.

For some individuals, especially those with persistent symptoms, brain-based approaches may be explored as part of a broader care plan.

Understanding fMRI-guided TMS therapy for mental health

fMRI-guided TMS therapy is a non-invasive, brain-based treatment approach that focuses on how specific brain networks function.

Rather than relying only on symptom descriptions, this method uses functional MRI to map individual brain connectivity patterns involved in mood, impulse control, and emotional regulation.

How fMRI-guided TMS therapy works for mental health disorders

Functional MRI identifies areas of the brain that may be communicating inefficiently. Using this data, transcranial magnetic stimulation is guided to specific circuits rather than standard locations.

Targeted magnetic pulses are delivered to support healthier communication between brain regions involved in stress regulation, decision-making, and emotional balance.

Is fMRI-guided TMS effective for depression and co-occurring conditions?

Research published in the National Library of Medicine suggests that disrupted brain circuits play a role in both mood disorders and substance-related behaviors. Clinical studies have explored TMS to influence craving, emotional regulation, and executive function, though its role in addiction recovery is still being studied.

Outcomes vary between individuals, but some patients explore this approach when symptoms persist despite traditional care or when they are seeking a non-medication, brain-based option.

Common TMS therapy side effects explained

fMRI-guided TMS therapy is generally well tolerated. When side effects occur, they are typically mild and temporary.

Commonly reported effects may include:

• Scalp discomfort during treatment
• Mild headache after sessions
• Temporary fatigue

Serious side effects are rare, and patients are carefully screened before starting treatment.

What to expect during and after TMS treatment

fMRI-guided TMS therapy is delivered over a series of sessions, most often scheduled several times per week across multiple weeks. Each session is relatively short, and patients remain awake and alert throughout, with no anesthesia or recovery period required.

Before treatment begins, patients undergo functional MRI–based computational brain mapping. This advanced imaging process analyzes how different regions of the brain communicate with one another at rest and during specific activity patterns.

Rather than focusing only on brain structure, computational mapping identifies functional connectivity patterns, highlighting areas where neural networks may be underactive, overactive, or misfiring.

Using this data, clinicians design a personalized stimulation plan that targets the specific brain circuits involved in mood regulation, impulse control, stress response, or emotional processing.

During treatment, magnetic pulses are delivered to these mapped targets to help support healthier communication between brain regions. Sessions are repeated over time to encourage gradual, lasting changes in neural connectivity.

Progress is monitored regularly through clinical assessments and, when appropriate, follow-up brain imaging. Because computational brain data guide treatment, adjustments can be made if connectivity patterns shift or symptoms change. This allows care to remain flexible, personalized, and responsive rather than fixed.

After completing treatment, patients often notice gradual improvements in emotional regulation, mental clarity, or symptom intensity.

Outcomes vary among individuals, but the goal of fMRI-guided TMS therapy is to support long-term brain network stability by addressing dysfunction at the circuit level rather than just surface-level symptoms.

TMS therapy as part of mental health recovery

fMRI-guided TMS therapy is not a replacement for comprehensive care. It is often considered as one component of a broader mental health strategy.

When is TMS considered in recovery planning?

This approach may be explored when:

• Mental health symptoms persist despite therapy or medication
• Medication is not well-tolerated
• A patient prefers a non-invasive, non-medication option
• Brain-based data may help guide personalized treatment planning

Mental health care at Neurotherapeutix in NYC

Neurotherapeutix provides personalized mental health and neurological services using fMRI-guided TMS therapy to support individuals with complex mental health needs.

Located on Manhattan’s Upper East Side, our clinic combines advanced neuroimaging with expert-led, compassionate care. Treatment planning is guided by individual brain connectivity patterns and clinical evaluation, ensuring care remains personalized and data-informed.

If you are exploring advanced mental health treatment options in New York City, you can request an appointment or contact our team to learn more.

Frequently asked questions about rehab, mental health, and TMS

Can mental health disorders contribute to substance use?

Yes. Conditions such as anxiety, depression, and trauma can increase vulnerability to substance use, especially when symptoms are unmanaged.

Is TMS therapy used alongside addiction recovery?

TMS may be explored as part of a broader mental health plan, especially when emotional regulation or mood symptoms remain challenging.

Are TMS therapy side effects long-lasting?

No. Most side effects are temporary and resolve shortly after sessions.

Who is a good candidate for TMS mental health treatment?

Candidates are determined through clinical evaluation and brain imaging to ensure the approach is appropriate and safe.

When should someone seek mental health treatment in NYC?

If symptoms interfere with daily life, worsen over time, or feel difficult to manage alone, professional evaluation can help guide next steps.